The role of mTOR inhibition as second-line therapy in...

Expert Review of Anticancer Therapy 2017 / 03 Vol. 17; Iss. 3

The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges

González-Larriba, José Luis, Maroto, Pablo, Durán, Ignacio, Lambea, Julio, Flores, Luis, Castellano, Daniel, the Changing Group,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Expert Review of Anticancer Therapy
DOI:
10.1080/14737140.2017.1273774
Date:
March, 2017
File:
PDF, 1019 KB
english, 2017
Conversion to is in progress
Conversion to is failed